URG Form 4: CFO Exercises Options and Sells 252,087 Shares on 09/24/2025
Rhea-AI Filing Summary
Roger L. Smith, Chief Financial Officer of Ur‑Energy Inc. (URG), executed option exercises and a contemporaneous sale on 09/24/2025. He exercised 252,087 options at an exercise price of C$0.63 (US$0.4535 per share using the reported FX rate) to acquire 252,087 common shares and then sold those 252,087 shares at C$2.3366 (US$1.6819 per share). After these transactions, Mr. Smith beneficially owned 632,175 common shares directly and held an additional 252,087 shares underlying options exercisable through 11/13/2025, for total reported direct beneficial interests reflected as 884,262 prior to the sale and 632,175 following the sale. The option grant date was 11/13/2020 with vesting in three annual tranches.
Positive
- 252,087 options exercised at the reported exercise price (C$0.63 / US$0.4535 equivalent)
- Complete disclosure of FX conversion used to translate Canadian dollar amounts to US dollars
- Vesting history provided for the 11/13/2020 option grant (three tranches: 11/13/2021, 11/13/2022, 11/13/2023)
Negative
- 252,087 shares sold on 09/24/2025, reducing direct beneficial ownership from 884,262 to 632,175 shares
- No cash proceeds total disclosed in USD or CAD beyond per‑share sale price and FX conversion
Insights
TL;DR Insider exercised previously granted options and sold the resulting shares the same day, materially changing direct holdings.
Mr. Smith exercised 252,087 options granted on 11/13/2020 at C$0.63 per share (US$0.4535 equivalent) and sold the same 252,087 shares at C$2.3366 (US$1.6819 equivalent) on 09/24/2025. The reported transactions reduced his direct beneficial ownership from 884,262 shares to 632,175 shares. These are routine Section 16 disclosures of option exercise and sale; the filing documents exact quantities, prices, and FX conversion used. For investors, the key facts are the option grant details, exercisable/expiration timeline through 11/13/2025, and the immediate disposition of the exercised shares.
TL;DR Filing documents a standard insider exercise-and-sale with fully disclosed terms and vesting history.
The Form 4 shows the options were granted 11/13/2020 and vested in three equal tranches on 11/13/2021, 11/13/2022 and 11/13/2023. The report provides precise FX conversions used to translate Cdn$ prices to US$ equivalents. The submission is signed and dated 09/25/2025, meeting disclosure formalities. The filing contains no additional corporate actions or deviations from standard Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common share options (right to buy) | 252,087 | $0.00 | -- |
| Exercise | Common Shares | 252,087 | $0.4535 | $114K |
| Sale | Common Shares | 252,087 | $1.6819 | $424K |
Footnotes (1)
- The options were exercised and the shares were acquired at $0.63 Canadian dollars, $0.4535 U.S. dollars is the equivalent price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7198). The shares were sold at $2.3366 Canadian dollars, $1.6819 U.S. dollars is the equivalent of the sales price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7198). The 252,087 options were granted on 11/13/2020 and vested and became exercisable as follows: 84,029 on 11/13/2021; 84,029 on 11/13/2022; and 84,029 on 11/13/2023.